R

    Rockwell Medical Inc (RMTI)

    Official site

    HEALTHCARE • DRUG MANUFACTURERS - SPECIALTY & GENERIC • NASDAQ

    $8.31
    +0.14 (+1.71%)

    Market Cap: $32.93M

    Last updated: Sep 01, 2026 at 10:00 AM ET

    Earnings

    Performance (10Y)

    Beat Rate
    55%(22/40)
    Avg Surprise
    +7.21%

    Upcoming Estimates

    Sep 30, 2026
    EPS Consensus$-0.17
    Range$-0.20 - $-0.13
    2 analysts
    EPS RevisionsNo revisions (7d)
    0
    1
    30d
    EPS Estimate Drift
    90d ago$-0.15+9.1%
    60d ago$-0.20-21.2%
    30d ago$-0.15+9.1%
    7d ago$-0.15+9.1%
    Current$-0.17
    Revenue Consensus
    $18M
    Range$18M - $18M
    2 analysts
    Dec 31, 2026
    EPS Consensus$-0.46
    Range$-0.57 - $-0.34
    2 analysts
    Revenue Consensus
    $18M
    Range$18M - $18M
    2 analysts
    PeriodReportedEst.SurpriseB/MYoY
    Dec 26EST
    		-$-0.46---
    Sep 26EST
    		-$-0.17---
    Jun 26
    		$-0.34$-0.17-100.00%Miss+32.0%
    Mar 26
    		$-0.40$-0.25-60.00%Miss+0.0%
    Dec 25
    		$-0.01N/A+77.78%Beat+50.0%
    Sep 25
    		$-0.50$-0.45-11.11%Miss-200.0%
    Jun 25
    		$-0.50$-0.50+0.00%Beat-600.0%
    Mar 25
    		$-0.40$-0.50+20.00%Beat+33.3%
    Dec 24
    		$-0.02$0.02-200.00%Miss+60.0%
    Sep 24
    		$0.50$0.10+400.00%Beat+157.5%
    Jun 24
    		$0.10N/A+128.57%Beat+105.9%
    Mar 24
    		$-0.60$-0.40-50.00%Miss-500.0%
    Dec 23
    		$-0.05$-0.07+28.57%Beat+96.4%
    Sep 23
    		$-0.87$-0.90+3.33%Beat+78.3%
    Jun 23
    		$-1.69$-1.20-40.83%Miss+69.8%
    Mar 23
    		$-0.10$-0.16+37.50%Beat+98.8%
    Dec 22
    		$-1.40N/A+64.10%Beat-1455.6%
    Sep 22
    		$-4.00$-3.70-8.11%Miss+54.5%
    Jun 22
    		$-5.60$-8.10+30.86%Beat+43.4%
    Mar 22
    		$-8.40$-7.70-9.09%Miss+4.5%
    Dec 21
    		$-0.09N/A+90.91%Beat+90.9%
    Sep 21
    		$-8.80$-8.25-6.67%Miss+20.0%
    Jun 21
    		$-9.90$-8.80-12.50%Miss-3.4%
    Mar 21
    		$-8.80$-9.90+11.11%Beat+33.3%
    Dec 20
    		$-0.99$-0.93-6.45%Miss+18.2%
    Sep 20
    		$-11.00$-7.70-42.86%Miss+16.7%
    Jun 20
    		$-9.57$-15.40+37.86%Beat+51.7%
    Mar 20
    		$-13.20$-13.20+0.00%Beat-700.0%
    Dec 19
    		$-1.21$-1.36+11.03%Beat+35.3%
    Sep 19
    		$-13.20$-17.23+23.39%Beat-1100.0%
    Jun 19
    		$-19.80$-17.60-12.50%Miss-718.2%
    Mar 19
    		$-1.65$-1.98+16.67%Beat-15.4%
    Dec 18
    		$-1.87$-1.43-30.77%Miss+90.6%
    Sep 18
    		$-1.10$-1.65+33.33%Beat+90.0%
    Jun 18
    		$-2.42$-1.43-69.23%Miss+84.3%
    Mar 18
    		$-1.43$-1.54+7.14%Beat-44.4%
    Dec 17
    		$-19.80$-13.20-50.00%Miss-80.0%
    Sep 17
    		$-11.00$-11.00+0.00%Beat-11.1%
    Jun 17
    		$-15.40$-11.00-40.00%Miss-
    Mar 17
    		$-0.99$-0.93-6.45%Miss-
    Dec 16
    		$-11.00$-11.55+4.76%Beat-
    Sep 16
    		$-9.90$-12.10+18.18%Beat-

    Key Metrics

    Valuation
    P/E Ratio-6.65EV/EBITDA30.21x
    Price/FCF21.36xFCF Yield4.68%
    Profitability
    Profit Margin-7.33%Operating Margin-5.97%
    ROE-15.50%ROIC1.22%
    Financial Health
    Debt/Equity0.26xInterest Coverage0.54x
    Current Ratio3.25xQuick Ratio3.00x
    Trading Statistics
    Beta1.62Avg Volume30.33K
    52-Week High$19.1052-Week Low$4.88

    Technical Indicators Dashboard

    Moving Averages

    SMA 10$7.88
    SMA 20$7.60
    SMA 50$6.79
    SMA 200$8.49
    EMA 10$7.90
    EMA 20$7.62
    EMA 50$7.27
    EMA 200$8.52

    MACD

    Line: 0.35Signal: 0.32Hist: 0.03

    ADX

    ADX: 58.4+DI: 21.0-DI: 4.4

    Aroon & PSAR

    Aroon Up100.0
    Aroon Down40.0
    PSAR$7.40

    Bollinger Bands

    Upper Band$8.38
    Lower Band$6.82
    %B Position2058%(Upper)
    Band Width0.95

    RSI (14-Day)

    Neutral
    66.9

    Momentum Oscillators

    Stoch %K79.7
    Stoch %D76.6
    Williams %R-11.7
    ROC (10d)11.0%
    Momentum0.82
    CCI (20d)141.3
    MFI (14d)88.3

    Volatility Measures

    ATR (14d)$0.72(8.7%)
    StdDev (20d)0.39
    Hist Vol54.8%(High)

    Volume Flow

    VWAP$8.20
    OBV2.1M
    AD Line41.1B
    CMF (20d)0.117

    Volume Metrics

    Avg Vol (20d)30.9K
    Vol Ratio1.6x(High)
    VWMA (20d)$7.62

    Pivot Points

    R3$8.96
    R2$8.62
    R1$8.39
    Pivot Point$8.05
    S1$7.82
    S2$7.48
    S3$7.25

    Advanced Oscillators

    TSI26.45
    Ultimate Osc58.3
    KST216.25

    Financial Data

    QuarterJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023
    Total Revenue$17.78M$17.34M$18.35M$15.93M$16.07M$18.91M$24.66M$28.32M$25.83M$22.68M$22.09M$23.77M
    Cost of Revenue$14.54M$14.44M$14.47M$13.65M$13.57M$15.87M$21.03M$22.08M$21.28M$19.61M$19.22M$21.57M
    Gross Profit$3.24M$2.90M$3.88M$2.27M$2.50M$3.04M$3.63M$6.24M$4.55M$3.06M$2.87M$2.20M
    Operating Expenses$4.30M$4.38M$4.28M$3.86M$3.85M$4.40M$4.15M$4.30M$4.04M$4.39M$3.42M$3.94M
    R&D$40,000$0$0$0$0$0$1,000$0$0$18,000$168,000$494,000
    SG&A$3.69M$3.81M$3.74M$3.33M$3.28M$3.69M$3.31M$3.58M$3.45M$3.78M$2.71M$2.89M
    Operating Income$-1,061,000$-1,480,000$-398,000$-1,584,000$-1,349,000$-1,360,000$-519,000$1.94M$515,000$-1,324,000$-547,000$-1,737,000
    Interest Income$40,000$37,000$44,000$55,000$69,000$66,000$29,000$30,000$9,000$24,000$42,000$56,000
    Interest Expense$281,000$282,000$286,000$285,000$276,000$277,000$289,000$302,000$232,000$431,000$1.11M$411,000
    Income Before Tax$-1,172,000$-1,605,000$-554,000$-1,753,000$-1,492,000$-1,515,000$-756,000$1.66M$343,000$-1,731,000$-1,512,000$-1,872,000
    Income Tax Expense$0$0$0$0$0$0$0$0$0$0$0$0
    Net Income$-1,172,000$-1,605,000$-554,000$-1,753,000$-1,492,000$-1,515,000$-756,000$1.66M$343,000$-1,731,000$-1,512,000$-1,872,000
    EBITDA$-349,000$-761,000$323,000$-890,000$-634,000$-677,000$136,000$2.57M$1.15M$-560,000$834,000$-861,000
    EBIT$-931,000$-1,360,000$-312,000$-1,523,000$-1,285,000$-1,304,000$-496,000$1.94M$566,000$-1,324,000$-547,000$-1,517,000
    * Some calculated fields are derived from available data when not provided by source

    Related GNG Research

    No research available

    Be the first to write about RMTI

    Government Contracts

    Gov Obligations (TTM)
    -$2065
    Gov Obligations / Revenue
    0.0%
    Obligations YoY
    N/A
    Active Awards
    1
    New Awards (TTM)
    0
    Avg Remaining Term
    N/A

    Federal contract obligations are bookings recorded by the awarding agency, not recognized revenue. They can exceed 100% of revenue and can be negative when contracts are de-obligated. Source: USAspending.gov prime awards, data through Jul 31, 2026.

    News

    RMTI: Reverse Split And 2026 Earnings Guidance Will Support Future Rebound

    Analysts have reduced their price target for Rockwell Medical (RMTI) from $30 to $20, reflecting a lower assumed future P/E multiple and adjusted valuation assumptions. Despite this, the company reiterated its 2026 earnings guidance, targeting net sales of US$70.0 million to US$75.0 million, and announced a 1-for-10 reverse stock split effective July 1, 2026. The valuation changes include a slight adjustment to the discount rate and revenue growth, an increase in net profit margin, and a significant reduction in the future P/E ratio.

    Simply Wall Street•8/19/26•
    Neutral

    Rockwell Medical, Inc. 2026 Q2 - Results - Earnings Call Presentation (NASDAQ:RMTI) 2026-08-17

    Rockwell Medical, Inc. (RMTI) published its Q2 2026 earnings call presentation on August 17, 2026. This article, written by SA Transcripts, provides access to the slide deck presented in conjunction with the earnings call. It highlights the company's financial results for the second quarter of 2026.

    Seeking Alpha•8/18/26•
    Neutral

    Earnings call transcript: Rockwell Medical Q2 2026 revenue rises 11%

    Rockwell Medical reported an 11% increase in Q2 2026 revenue to $17.8 million, driven by new customers in the Western U.S., stronger existing orders, and price increases, though it slightly missed Wall Street's earnings and sales forecasts. The company narrowed its net loss and generated positive operating cash flow, leading to a modest stock increase in premarket trading. Management reiterated full-year 2026 guidance and outlined a strategy for continued growth, including a new medical device opportunity.

    Investing.com•8/14/26•
    Somewhat-Bullish

    Rockwell Medical Releases Q2 2026 Financial Results

    Rockwell Medical, Inc. announced strong Q2 2026 financial results, significantly beating Wall Street expectations with an adjusted loss per share of $0.04 against an estimated $0.24 loss. The company reported revenue of $17.8 million, an 11% increase year-over-year, driven by expanding demand for its hemodialysis products. Management provided full-year revenue guidance of $70.0 million to $75.0 million, and analysts maintain a positive outlook on the stock.

    AlphaStreet•8/14/26•
    Bullish

    Rockwell Medical Q2 2026 slides: narrowing losses, targeting profitability

    Rockwell Medical reported narrowing losses and increased revenue in Q2 2026, driven by new customers and operational efficiencies, despite narrowly missing analyst expectations. The company is progressing towards its goal of positive adjusted EBITDA for the full year 2026 and aims for significant growth and profitability by 2029 through strategic initiatives and portfolio diversification. Rockwell operates in a growing hemodialysis market, serving major providers and hospitals, and plans to expand its product offerings and global presence.

    Investing.com•8/13/26•
    Somewhat-Bullish

    Frequently Asked Questions About RMTI

    Does RMTI pay dividends?
    Rockwell Medical Inc (RMTI) does not currently pay a regular dividend.
    What is RMTI's market cap?
    Rockwell Medical Inc (RMTI) has a market capitalization of $32.93M with a current stock price of $8.31.

    Get full access to GNG Research

    Create a free account to access portfolio tracking, advanced tools, and more.

    Create Free AccountLog In